Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Karuna rapeutics

Something Unusual Is Happening Right Now With Biotech Stocks

Biotech stocks have swung sharply higher, buoyed by several factors. Could they be poised to lead the market though the next big upturn?

Investors Business Daily

These 10 Non-Covid Biotech Stocks Are Up 40% Or More This Year

These 10 Non-Covid Biotech Stocks Are Up 40% Or More This Year

Biotech stocks are scorching right now. But the best of the best have strong gains. Those include 10 with at least 40% growth this year.

Investors Business Daily

This Pfizer Spinout Is Leaving Nothing to Chance

This Pfizer Spinout Is Leaving Nothing to Chance

Cerevel Therapeutics more than doubled its cash balance to keep pace with Karuna Therapeutics in a head-to-head showdown.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Analyst Ratings for Karuna Therapeutics

Analysts have provided the following ratings for Karuna Therapeutics (NASDAQ:KRTX) within the last quarter:

Analyst Ratings for Karuna Therapeutics

Karuna Therapeutics (NASDAQ:KRTX) has observed the following analyst ratings within the last quarter:

Karuna Therapeutics: Q1 Earnings Insights

Karuna Therapeutics (NASDAQ:KRTX) reported its Q1 earnings results on Thursday, May 5, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

What 4 Analyst Ratings Have To Say About Karuna Therapeutics

Karuna Therapeutics (NASDAQ:KRTX) has observed the following analyst ratings within the last quarter:

inkl

Read news from The Economist, FT, and more,
with one subscription

Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2022

Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2022

1

Organisations

Advanced Micro Devices

Food and Drug Administration

Dell Technologies

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play